Sign in
4

Changes in Ownership

Passage BIO, Inc. Filed Acc 0001787297-22-000005

Options or other derivatives

  • Chief Res. & Develop Officer acquired 157,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Salinas Eliseo Oreste Chief Res. & Develop Officer 2022-02-10 Grant or award · Stock Option (right to buy) +157,500 157,500 D
Loading xslF345X03/primary_doc.xml…